D1.2.18 (HL)—Polypeptide modification

Polypeptide modification can convert an inactive precursor into a functional protein through cleavage, folding or chemical processing after translation in cells.

Syllabus
First assessment 2025
Objective
D1.2.18
Level
HL

Exam analysis

Chance of appearing1%of analysed past papers
Latest appearanceMay 2016
Most common paperPaper2
Typical marks2

Common command terms

  • Suggest

Recent exam appearances

May 2016Paper2 ["HL"] · TZ01(g)[ 2 ]D1.2.18 (HL)—Polypeptide modification
Practice this objective

Coverage 2016–2016 · Updated 16 Jul 2026

Polypeptides Are Modified after Translation

HL only

Many translated polypeptides must be folded, cleaved or chemically modified before becoming functional proteins.

Insulin provides a required two-stage example: removal of the signal peptide converts pre-proinsulin to proinsulin; later removal of the connecting C-peptide converts proinsulin to mature insulin, whose A and B chains remain linked by disulfide bonds.

Pre-proinsulin → signal peptide removed → proinsulin folds/disulfide bonds form → C-peptide removed → functional insulin.

Cleavage changes one precursor polypeptide into the mature hormone structure able to bind its receptor appropriately.

Translation alone does not guarantee a functional protein. The insulin example is processing after translation, not alternative splicing of insulin exons.

Polypeptide modification

HL only

Assessment in practice

2 marks
How it is assessed

This objective is assessed through structured response, commonly using Suggest.

Command terms

Suggest

What earns marks

Build the answer around this relationship: A newly translated polypeptide may be an inactive precursor.

Representative question

Question 1

[Maximum number: 2]

Insulin is produced by cutting C -peptide from the precursor molecule proinsulin. Suggest why group 1 has a greater level of C-peptide than group 2.

HL Protein Synthesis Details

HL only

RNA polymerase reads template DNA 3' to 5' and synthesizes RNA 5' to 3'; ribosomes translate mRNA codons in the 5' to 3' direction. Promoters mark transcription start regions and orientation; transcription factors help RNA polymerase bind and initiate in eukaryotes. Non-coding DNA does not code for polypeptide amino acid sequences and includes introns, regulatory sequences, telomeres, rRNA genes, and tRNA genes. Eukaryotic pre-mRNA is modified before export and translation by adding a 5' cap and poly-A tail and removing introns by splicing. Alternative splicing joins different exon combinations from one pre-mRNA, so one gene can produce multiple protein variants in different cells or stages. Translation initiation assembles ribosomal subunits at the start codon AUG; initiator tRNA enters the P site and A, P, and E sites organize tRNA movement. Newly made polypeptides may be folded, cleaved, or chemically modified; preproinsulin processing to active insulin is a key example. Proteasomes degrade tagged, damaged, or unneeded proteins; amino acid recycling supports new protein synthesis and proteome quality control.

Concept essentials

  • A newly translated polypeptide may be an inactive precursor.
  • Cleavage can remove peptide segments to activate a protein.
  • C-peptide is produced when proinsulin is processed to insulin.
  • Protein function can depend on processing after translation.